MedTrace Logo

The Impact of Serelys PMS on Symptoms of PMS

NCT03298607 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-10-15

No results posted yet for this study

Summary

The objective of the present study is to better define and evaluate Serelys PMS in terms of the impact on the different premenstrual syndrome (PMS) symptoms , tolerance, satisfaction and overall quality of life of women with known discomforts during the premenstrual period. The data from this study will be compared to data when the two different ingredients are given as monotherapy.

Conditions

  • Premenstrual Syndrome

Interventions

DIETARY_SUPPLEMENT

Placebo

2 months treatment

DIETARY_SUPPLEMENT

Serelys PMS

2 months treatment

Sponsors & Collaborators

  • Serelys Pharma

    collaborator UNKNOWN

  • Jens Rikardt Andersen

    lead OTHER

Principal Investigators

  • Kaj Winther Hansen, MD · UCopenhagen, Department of Nutrition, Exercise and Sport

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-30
Primary Completion
2018-06-01
Completion
2018-06-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03298607 on ClinicalTrials.gov